Quent Capital LLC Sells 281 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Quent Capital LLC cut its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 7.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,515 shares of the company’s stock after selling 281 shares during the quarter. Quent Capital LLC’s holdings in Acadia Healthcare were worth $139,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. GAMMA Investing LLC lifted its position in Acadia Healthcare by 57.1% during the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after buying an additional 241 shares in the last quarter. Blue Trust Inc. lifted its position in Acadia Healthcare by 69.4% during the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock worth $33,000 after buying an additional 345 shares in the last quarter. Nisa Investment Advisors LLC lifted its position in Acadia Healthcare by 40.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock worth $41,000 after buying an additional 301 shares in the last quarter. Covestor Ltd lifted its position in Acadia Healthcare by 834.4% during the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company’s stock worth $72,000 after buying an additional 1,018 shares in the last quarter. Finally, Fifth Third Bancorp lifted its position in Acadia Healthcare by 56.0% during the 4th quarter. Fifth Third Bancorp now owns 1,264 shares of the company’s stock worth $50,000 after buying an additional 454 shares in the last quarter.

Analyst Ratings Changes

Several brokerages have commented on ACHC. KeyCorp raised shares of Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 price target on the stock in a research report on Tuesday, January 7th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $52.00 target price on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Royal Bank of Canada reiterated an “outperform” rating and set a $64.00 price target on shares of Acadia Healthcare in a report on Friday, January 10th. StockNews.com lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, January 6th. Finally, Barclays reduced their target price on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research note on Friday, November 22nd. One research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, Acadia Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $70.22.

Acadia Healthcare Stock Down 1.7 %

ACHC stock opened at $41.28 on Thursday. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $3.83 billion, a PE ratio of 13.53, a PEG ratio of 1.75 and a beta of 1.30. Acadia Healthcare Company, Inc. has a 1-year low of $36.50 and a 1-year high of $87.77. The business’s 50 day simple moving average is $42.08 and its 200 day simple moving average is $54.33.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.